Company Overview and News

2
Boralex, Invenergy Ontario clean-power projects hit by Ford

17h thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
BAMGF H BRLXF NPIFF BAMKF HRNNF BAM TERP NPI

4
Innergex Deserves To Trade At A Premium Valuation

2018-07-13 seekingalpha
Innergex Renewable Energy (OTCPK:INGXF) (TSX:INE) is a Canada-based renewable power producer with a focus on hydroelectric, wind power and solar photovoltaic projects. The company is currently trading at a premium valuation to its peers. Its valuation is supported by its growth potential, long weighted-average PPA duration, and low maintenance expenditure. However, its debt load is quite high and rising benchmark bond yield can impact its share price.
RNW INE AXY NPIFF MGMXF INGXF MGMXD TRSWF TTM AQN NPI

0
Northland Announces Date for 2018 Second Quarter Financial Results Release and Details of Investor Call

2018-07-09 globenewswire
TORONTO, July 09, 2018 (GLOBE NEWSWIRE) -- Northland Power Inc. (“Northland”) (TSX:NPI) announced it will release its 2018 second quarter financial results after market close on August 8, 2018. Northland management will hold an investor conference call at 10:00 a.m. Eastern Time (ET) on Thursday, August 9, 2018, followed by a question and answer period.
NPIFF NPI

0
Northland Power Announces New $1.25 Billion Corporate Credit Facility

2018-06-22 globenewswire
Not for distribution to U.S. newswire services or for dissemination in the United States or its possessions. Any failure to comply with this restriction may constitute a violation of U.S. securities law.
NPIFF NPI

0
Northland Power’s Hai Long Offshore Wind Project Awarded Additional 744 Megawatts in Taiwan Auction

2018-06-22 globenewswire
TORONTO, June 22, 2018 (GLOBE NEWSWIRE) -- Northland Power Inc. (“Northland”) (TSX:NPI) today announced that the Taiwan Bureau of Energy (“BOE”) has awarded 232 megawatts (“MW”) to the Hai Long 2 offshore wind farm (“Hai Long 2”) and 512 MW to the Hai Long 3 offshore wind farm (“Hai Long 3”) under Taiwan’s offshore wind auction program. These awards are separate from and in addition to the 300 MW in 2024 that Hai Long 2 was allocated by the Taiwan BOE on April 30, 2018 under Taiwan’s Feed-in-Tariff (“FIT”) program.
NPIFF NPI

0
Should You Buy Northland Power And Its Future Development Pipeline?

2018-06-08 seekingalpha
The company has two offshore wind development projects that should increase its power generation capacity by nearly 20%.
RNW NPIFF TRSWF NPI

0
Cross-strait risks cannot be ignored, insurer warns offshore wind farm firms chasing lucrative Taiwan projects

2018-05-27 scmp
Heightened geopolitical tensions in the Taiwan Strait, the narrow sea channel between Taiwan and mainland China that has become an offshore wind farms investment hotspot, has raised concerns on the adequacy of insurance coverage for the sector, according to an insurer focused on renewable energy.
NPIFF NPI

0
Northland Power Announces Retirement of CEO John Brace and Appointment of Mike Crawley as Chief Executive Officer, Effective August 4, 2018

2018-05-22 globenewswire
TORONTO, May 22, 2018 (GLOBE NEWSWIRE) -- Northland Power Inc. (“Northland”) (TSX:NPI) today announced that Chief Executive Officer John Brace will retire on August 4, 2018 after 30 years with the company. Mike Crawley, currently Northland’s Executive Vice President, Development has been appointed to the role of Chief Executive Officer, effective August 4, 2018. Mr. Brace and Mr. Crawley will work together to ensure a smooth transition.
NPIFF NPI

0
Northland Power Renews Preliminary Base Shelf Prospectus

2018-05-15 globenewswire
Not for distribution to U.S. newswire services or for dissemination in the United States or its possessions. Any failure to comply with this restriction may constitute a violation of U.S. securities law.
NPIFF NPI

0
Northland Power Reports Strong First Quarter Results With Free Cash Flow Up 256% and Adjusted EBITDA Up 47%

2018-05-09 globenewswire
TORONTO, May 09, 2018 (GLOBE NEWSWIRE) -- Northland Power Inc. (“Northland” or the “Company”) (TSX:NPI) today reported financial results for the three months ended March 31, 2018.
NPIFF NPI

0
Northland Announces Date for 2018 First Quarter Financial Results Release and Details of Investor Call

2018-04-06 globenewswire
TORONTO, April 06, 2018 (GLOBE NEWSWIRE) -- Northland Power Inc. (“Northland”) (TSX:NPI) (TSX:NPI.PR.A) (TSX:NPI.PR.B) (TSX:NPI.PR.C) (TSX:NPI.DB.B) (TSX:NPI.DB.C) announced it will release its 2018 first quarter financial results after market close on May 9, 2018. Northland management will hold an investor conference call at 10:00 a.m. Eastern Daylight Time (EDT) on Thursday, May 10, 2018, followed by a question and answer period.
NPIFF NPI

0
Northland Announces the Appointment of John Brace to Its Board of Directors

2018-04-04 globenewswire
TORONTO, April 04, 2018 (GLOBE NEWSWIRE) -- Northland Power Inc. ("Northland") (TSX:NPI) (TSX:NPI.PR.A) (TSX:NPI.PR.B) (TSX:NPI.PR.C) (TSX:NPI.DB.B) (TSX:NPI.DB.C) announced that it has expanded its Board of Directors from six to seven members and has appointed Chief Executive Officer John Brace to the additional Board position, effective today. Along with Northland’s other board members, John will stand for re-election at Northland’s Annual General Meeting on May 23rd, 2018.
NPIFF NPI

0
Acquisition of Northland Power Inc. Common Shares

2018-03-24 globenewswire
TORONTO, March 23, 2018 (GLOBE NEWSWIRE) -- James C. Temerty, Chair of Northland Power Inc. (TSX:NPI) (“Northland”), 30 St. Clair Avenue West, Suite 1200, Toronto, Ontario M4V 3A1 announced today that on March 23, 2018, a trust controlled by Mr. Temerty acquired ownership of common shares (“Shares”) of Northland in open market purchases on the Toronto Stock Exchange (the “Transaction”). In particular, 150,000 Shares were acquired for an average price of $22.
NPIFF NPI

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

8h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

9h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to TSX:NPI / Northland Power Inc. on message board site Silicon Investor.

Genius Products (GNPI) ANPI: Angiotech Pharmaceuticals
Network Peripherals (NPIX) can Lead FastEthernet market??? Richtree- Marche Movenpick of North America
Formerly MNPI, now CPQ